Long-term outcome after biologic versus mechanical aortic valve replacement in 841 patients

被引:94
作者
Peterseim, DS
Cen, YY
Cheruvu, S
Landolfo, K
Bashore, TM
Lowe, JE
Wolfe, WG
Glower, DD
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
关键词
D O I
10.1016/S0022-5223(99)70368-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The purpose of this study was to optimize selection criteria of biologic versus mechanical valve prostheses for aortic valve replacement. Methods: Retrospective analysis was performed for 841 patients undergoing isolated, first-time aortic valve replacement with Carpentier-Edwards (n = 429) or St Jude Medical (n = 412) prostheses. Results: Patients with Carpentier-Edwards and St Jude Medical valves had similar characteristics. Ten-gear survival was similar in each group (Carpentier-Edwards 54% +/- 3% versus St Jude Medical 50% +/- 6%; P =.4), Independent predictors of worse survival were older age, renal or lung disease, ejection fraction less than 40%, diabetes, and coronary disease. Carpentier-Edwards versus St Jude Medical prostheses did not affect survival (P =.4). Independent predictors of aortic valve reoperation were younger age and Carpentier-Edwards prosthesis. The linearized rates of thromboembolism were similar, but the linearized rate of hemorrhage was lower with Carpentier-Edwards prostheses (P <.01), Perivalvular leak within 6 months of operation was more likely with St Jude Medical than with Carpentier-Edwards prostheses (P =.02). Estimated 10-year survival free from valve-related morbidity was better for the St Jude Medical valve in patients aged less than 65 Sears and was better for the Carpentier-Edwards valve in patients aged more than 65 years. Patients with renal disease, lung disease tin patients more than age 60 years), ejection fraction less than 40%, or coronary disease had a life expectancy of less than 10 years. Conclusions: For first-time, isolated aortic valve replacement, mechanical prostheses should be consider ed in patients under age 65 years with a life expectancy of at least 10 years. Bioprostheses should be considered in patients over age 65 years or with lung disease tin patients over age 60 Sears), renal disease, coronary disease, ejection fraction less than 40%, or a life expectancy less than 10 years.
引用
收藏
页码:890 / 897
页数:8
相关论文
共 50 条
  • [31] Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement
    Compagnone, Miriam
    Marchetti, Giulia
    Taglieri, Nevio
    Ghetti, Gabriele
    Bruno, Antonio Giulio
    Orzalkiewicz, Mateusz
    Marrozzini, Cinzia
    Reggiani, Maria-Letizia Bacchi
    Palmerini, Tullio
    Galie, Nazzareno
    Saia, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 318 : 27 - 31
  • [32] Long-term outcomes of aortic valve replacement with bioprosthetic and mechanical valves
    Balan, Santhia Seeva
    Eves, Patrick
    Francis, Jeevan
    Zamvar, Vipin
    SCOTTISH MEDICAL JOURNAL, 2023, 68 (02) : NP2 - NP3
  • [33] Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement
    Campos Guimaraes, Leonardo de Freitas
    Urena, Marina
    Wijeysundera, Harindra C.
    Munoz-Garcia, Antonio
    Serra, Vicenc
    Benitez, Luis M.
    Auffret, Vincent
    Cheema, Asim N.
    Amat-Santos, Ignacio J.
    Fisher, Quentin
    Himbert, Dominique
    Garcia del Blanco, Bruno
    Dager, Antonio
    Le Breton, Herve
    Paradis, Jean-Michel
    Dumont, Eric
    Pibarot, Philippe
    Rodes-Cabau, Josep
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (09)
  • [34] Long-term results of mechanical valve replacement: Isolated mitral valve replacement and mitral-aortic valve replacement
    Remadi, JP
    Duveau, D
    JOURNAL OF HEART VALVE DISEASE, 2004, 13 : S26 - S26
  • [35] Aortic complications after bicuspid aortic valve replacement: Long-term results
    Russo, CF
    Mazzetti, S
    Garatti, A
    Ribera, E
    Milazzo, A
    Bruschi, G
    Lanfranconi, M
    Colombo, T
    Vitali, E
    ANNALS OF THORACIC SURGERY, 2002, 74 (05) : S1773 - S1776
  • [36] Long-term outcome after transcatheter aortic valve implantation
    Bouleti, Claire
    Himbert, Dominique
    Iung, Bernard
    Alos, Benjamin
    Kerneis, Caroline
    Ghodbane, Walid
    Messika-Zeitoun, David
    Brochet, Eric
    Fassa, Amir-Ali
    Depoix, Jean-Pol
    Ou, Phalla
    Nataf, Patrick
    Vahanian, Alec
    HEART, 2015, 101 (12) : 936 - 942
  • [37] Statin treatment after surgical aortic valve replacement for aortic stenosis is associated with better long-term outcome
    Pan, Emily
    Nielsen, Susanne J.
    Landenhed-Smith, Maya
    Torngren, Charlotta
    Bjorklund, Erik
    Hansson, Emma C.
    Jeppsson, Anders
    Martinsson, Andreas
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (02)
  • [38] IMPACT OF EJECTION FRACTION ON LONG-TERM OUTCOME AFTER ELECTIVE AORTIC VALVE REPLACEMENT IN OCTOGENARIANS WITH AORTIC STENOSIS
    Shibayama, Kentaro
    Watanabe, Hiroyuki
    Sasaki, Shunsuke
    Mahara, Keitaro
    Fukui, Toshihiro
    Takanashi, Shuichiro
    Sumiyoshi, Tetsuya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E2038 - E2038
  • [39] Long-term outcomes after elective isolated mechanical aortic valve replacement in young adults
    Bouhout, Ismail
    Stevens, Louis-Mathieu
    Mazine, Amine
    Poirier, Nancy
    Cartier, Raymond
    Demers, Philippe
    El-Hamamsy, Ismail
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (04) : 1341 - +
  • [40] Impact of Ejection Fraction on Long-Term Outcome After Elective Aortic Valve Replacement in Octogenarians With Aortic Stenosis
    Shibayama, Kentaro
    Watanabe, Hiroyuki
    Tabata, Minoru
    Sasaki, Shunsuke
    Fukui, Toshihiro
    Umemura, Jun
    Takanashi, Shuichiro
    Sumiyoshi, Tetsuya
    CIRCULATION JOURNAL, 2012, 76 (07) : 1761 - 1767